US 12318413
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted A61KA61K2035/115A61K31/215
Quick answer
US patent 12318413 (Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome) held by The Board of Regents of the University of Texas System expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2035/115, A61K31/215, A61K35/04, A61K35/17